What To Know About FDA's 'Intended Use' Proposed Rule

Law360 (October 8, 2020, 5:26 PM EDT) -- On Sept. 23, the U.S. Food and Drug Administration published a new proposed rule amending Title 21 of the Code of Federal Regulations, Subsections 201.128 and 801.4 — the regulations defining "intended use."

Although the proposed codified language removes the knowledge-only prong from the definition — a helpful development from the industry's perspective — it also adds a potentially limiting proviso and a new provision that would allow the FDA to regulate a product based on its "design or composition."

The proposal represents the latest development in a long-running proceeding in which the FDA has both recognized the importance of clarity...

Stay ahead of the curve

In the legal profession, information is the key to success. You have to know what’s happening with clients, competitors, practice areas, and industries. Law360 provides the intelligence you need to remain an expert and beat the competition.


  • Access to case data within articles (numbers, filings, courts, nature of suit, and more.)
  • Access to attached documents such as briefs, petitions, complaints, decisions, motions, etc.
  • Create custom alerts for specific article and case topics and so much more!

TRY LAW360 FREE FOR SEVEN DAYS

Hello! I'm Law360's automated support bot.

How can I help you today?

For example, you can type:
  • I forgot my password
  • I took a free trial but didn't get a verification email
  • How do I sign up for a newsletter?
Beta
Ask a question!